Sen-Jam Pharmaceutical
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
223 Wall St Pmb 130, Huntington, New Yor...Phone Number
(201) 400-8083Website
www.sen-jam.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Sen-Jam Pharmaceutical
At Sen-Jam Pharmaceutical the company disrupt pain and inflammation. Sen-Jam Pharmaceutical's mission is to improve societal wellbeing by developing therapeutics that are safe, efficacious, and accessible by all. Sen-Jam repurposes small molecules to develop novel therapeutics for large unmet needs with a focus on improving clinical outcomes. Using patented proprietary technology and the accelerated 505(b)2 pathway, Sen-Jam is on a mission to revolutionize inflammatory pain treatment and its unwanted side effects.Explore more
Sen-Jam Pharmaceutical Org Chart
NZ
Global Director, Licensing
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sen-Jam Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Sen-Jam Pharmaceutical
Product Launch: Get notified when Sen-Jam Pharmaceutical launches new products
Check out if Sen-Jam Pharmaceutical is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Sen-Jam Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Sen-Jam Pharmaceutical recently announced quarterly report
Sen-Jam Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Sen-Jam Pharmaceutical had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Sen-Jam Pharmaceutical has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Sen-Jam Pharmaceutical
Find more new buyers
Compare Similar Companies to Sen-Jam Pharmaceutical
Compare insights from companies similar to Sen-Jam Pharmaceutical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sen-Jam Pharmaceutical is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sen-Jam Pharmaceutical is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sen-Jam Pharmaceutical.
Sen-Jam Pharmaceutical Tech Stack
A closer look at the technologies used by Sen-Jam Pharmaceutical
See more technologies
Most Recent Scoops
Partnership
Project
Partnership, Product Management, Governmental Affairs & Regulation, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Person-Based
Person-Based
Person-Based
Person-Based
Sen-Jam Pharmaceutical News & Media
Sen-Jam Pharmaceutical Advances Addiction Therapeutic Platform with Breakthrough Preclinical Results Leading to Patent for Stimulant Withdrawal
HUNTINGTON, N.Y., Oct. 17, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical, a clinical-stage biopharmaceutical company advancing affordable therapeutics for inflammation-driven disease, today announced a major step forward in combating addiction with the filing of a new U.S. provisional...Sen-Jam Pharmaceutical and KVK Tech Complete Final CMC Deliverables for SJP-002C, Paving the Way for Late-Stage Clinical Development
Completion of submission batches and NDA-ready CMC package strengthens regulatory foundation for upcoming Phase 2b/3 trials and underscores Sen-Jam's leadership in immunoregulation and inflammaging. HUNTINGTON, N.Y., Sept. 26, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical, in partnership.../DISREGARD RELEASE: Sen-Jam Pharmaceutical/ - Yahoo Finance
We are advised by Sen-Jam Pharmaceutical that journalists and other readers should disregard the news release, Sen-Jam Pharmaceutical Launches Healthspan Catalyst Fund Two Paths-- Tax-Deductible Giving via CataCap or Equity Crowdfunding on Wefunder, issued 22-Jul-2025 over PR Newswire.Sen-Jam Pharmaceutical Advances First-in-Class FDA Hangover Prevention Therapy, SJP-001, to Phase 2 Trials in Canada
Cliantha Research spearheads clinical study as growing evidence and investor enthusiasm converge around inflammation-based innovation. HUNTINGTON, N.Y., July 25, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical has initiated a Phase 2 clinical trial for its pioneering hangover prevention...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sen-Jam Pharmaceutical
Sign Up For FreeTo access detailed company insights
At Sen-Jam Pharmaceutical the company disrupt pain and inflammation. Sen-Jam Pharmaceutical's mission is to improve societal wellbeing by developing therapeutics that are safe, efficacious, and accessible by all. Sen-Jam repurposes small molecules to develop novel therapeutics for large unmet needs with a focus on improving clinical outcomes. Using... Read More
